AIkido Pharma Inc.

AIkido Pharma Inc. Stock Forecast & Price Prediction

Live AIkido Pharma Inc. Stock (DOMH) Price
$1.69

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$1.69

P/E Ratio

-0.34

Volume Traded Today

$12,200

Dividend

$0.12

52 Week High/low

3.20/1.50

AIkido Pharma Inc. Market Cap

$10.1M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $DOMH ๐Ÿ›‘

Before you buy DOMH you'll want to see this list of ten stocks that have huge potential. Want to see if DOMH made the cut? Enter your email below

DOMH Summary

Based on ratings from 0 stock analysts, the AIkido Pharma Inc. stock price is expected to decrease by 100% in 12 months. This is calculated by using the average 12-month stock price forecast for AIkido Pharma Inc.. The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.

DOMH Analyst Ratings

About 0 Wall Street analysts have assignedDOMH 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect AIkido Pharma Inc. to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on DOMH. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

DOMH stock forecast by analyst

These are the latest 20 analyst ratings of DOMH.

Analyst/Firm

Rating

Price Target

Change

Date


HC Wainwright & Co.

Buy


Maintains

Nov 11, 2022

DOMH Company Information

What They Do: Provides comprehensive financial and wealth management services.

Business Model: The company operates through two segments, Dominari Financial and Legacy AIkido, offering a range of services including brokerage, financial planning, investment banking, and asset management. It generates revenue through commissions on trading, advisory fees, asset management fees, and capital raising solutions for corporate clients.

Other Information: Founded in 1967 and based in New York, Dominari Holdings Inc. was previously known as AIkido Pharma Inc. and rebranded in December 2022. Its diverse offerings cater to both individual and corporate clients, positioning it well in the competitive financial services market.
DOMH
AIkido Pharma Inc. (DOMH)

When did it IPO

1980

Staff Count

26

Country

United States

Sector/Industry

Healthcare/Biotechnology

CEO

Mr. Anthony C. Hayes Esq.

Market Cap

$10.1M

AIkido Pharma Inc. (DOMH) Financial Data

In 2023, DOMH generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that DOMH's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$0

Revenue From 2021

$0

0.00 %
From Previous Year

Revenue From 2022

$0

0.00 %
From Previous Year

Revenue From 2023

N/A

0.00 %
From Previous Year
  • Revenue TTM $12.6M
  • Operating Margin TTM -79.1%
  • Gross profit TTM $0
  • Return on assets TTM -16.7%
  • Return on equity TTM -47.0%
  • Profit Margin -180.2%
  • Book Value Per Share 6.10%
  • Market capitalisation $10.1M
  • Revenue for 2021 $0
  • Revenue for 2022 $0
  • Revenue for 2023 N/A
  • EPS this year (TTM) $-3.86

AIkido Pharma Inc. (DOMH) Latest News

News Image

Mon, 11 Nov 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - Dominari Holdings Inc. has appointed Edward Deignan as VP of Finance and Accounting and Kyle Degruttola as Controller, enhancing its financial leadership team.

Why It Matters - Leadership changes in finance roles can signal a shift in strategy or company direction, impacting operational efficiency and financial performance, which are crucial for investor confidence and stock valuation.

News Image

Mon, 07 Oct 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - Dominari Holdings Inc. announced the appointment of James Hopkins as Managing Director Head of Capital Markets for its subsidiary, Dominari Securities LLC, to enhance its financial services offerings.

Why It Matters - The appointment of James Hopkins strengthens Dominari's capital markets expertise, enhancing its growth potential and signaling a commitment to expanding its financial services, which could boost investor confidence.

News Image

Tue, 13 Aug 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - Dominari Holdings Inc. (Nasdaq: DOMH) announced that its subsidiary, Dominari Securities LLC, has been approved as a Limited Underwriting Member of Nasdaq, allowing it to act as a principal underwriter.

Why It Matters - Dominari Holdings' approval as a Limited Underwriting Member enhances its market position, potentially increasing revenue streams and investor confidence in the company's growth trajectory.

News Image

Wed, 17 Apr 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - Dominari Holdings Inc. (Nasdaq: DOMH) has appointed Steve Kann and Andre Peschong as Managing Directors at its subsidiary, Dominari Securities LLC, to enhance its financial services capabilities.

Why It Matters - The addition of seasoned professionals enhances Dominari's leadership, potentially leading to improved strategic execution and growth, which can positively impact stock performance and investor confidence.

News Image

Fri, 15 Mar 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Dominari Holdings Inc. appointed Eric Newman as Executive Vice President of its subsidiary, Dominari Securities LLC, to enhance investment banking and brokerage operations.

Why It Matters - Eric Newman's appointment enhances Dominari Securities' investment banking and brokerage capabilities, potentially improving performance and shareholder value, which could positively impact stock prices.

News Image

Tue, 12 Mar 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Dominari Holdings Inc. has appointed Dr. Cosme Ordoรฑez as Head of Investment Banking for its subsidiary, Dominari Securities LLC, enhancing its healthcare sector coverage.

Why It Matters - The appointment of Dr. Cosme Ordoรฑez enhances Dominari Securities' expertise in healthcare investment banking, potentially improving deal flow and profitability, which can positively impact stock performance.

...

DOMH Frequently asked questions

The highest forecasted price for DOMH is $ from at HC Wainwright & Co..

The lowest forecasted price for DOMH is $ from from HC Wainwright & Co.

The DOMH analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.